Citation Impact
Citing Papers
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
Porcine Acute Phase Protein Concentrations in Different Diseases in Field Conditions
2006
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Chromosomal Heterogeneity of Various Mycoplasma hyopneumoniae Field Strains
1992
Recombinant Bordetella pertussis pertactin (P69) from the yeast Pichia pastoris: high-level production and immunological properties
1991
Changes in haptoglobin, C-reactive protein and pig-MAP during a housing period following long distance transport in swine
2007
The case for maternal vaccination against pertussis
2007
Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules
2013
Acellular Pertussis Vaccines--A Solution to the Pertussis Problem
1993
Pseudomonas Aeruginosa: Resistance to the Max
2011 Standout
ISApl1, a novel insertion element of Actinobacillus pleuropneumoniae, prevents ApxIV-based serological detection of serotype 7 strain AP76
2007
Antibiotics bioremediation: Perspectives on its ecotoxicity and resistance
2019 Standout
P.70 pertactin, an outer‐membrane protein from Bordetella parapertussis: cloning, nucleotide sequence and surface expression in Escherichia coli
1991
A comparison of five methods for extraction of bacterial DNA from human faecal samples
2002
Increased levels of tumor necrosis factor and interleukin 1 in bronchoalveolar lavage fluids from pigs infected with Mycoplasma hyopneumoniae
1993
Characterization of haemagglutinin from Bordetella bronchiseptica
1991
Biological roles of glycans
2016 Standout
AIDS-ASSOCIATED MYCOPLASMAS
1994 StandoutNobel
A standardized bacterial taxonomy based on genome phylogeny substantially revises the tree of life
2018 Standout
Cloning, nucleotide sequence and heterologous expression of the protective outer-membrane protein P.68 pertactin from Bordetella bronchiseptica
1992
Construction and characterization of Bordetella pertussis mutants lacking the vir‐regulated P.69 outer membrane protein
1991
Contribution of ParE Mutation and Efflux to Ciprofloxacin Resistance inPseudomonas aeruginosaClinical Isolates
2008
Heterologous protein expression in the methylotrophic yeastPichia pastoris
2000 Standout
Virulence of Bordetella bronchiseptica: role of adenylate cyclase-hemolysin
1993
Mobile Genetic Elements Associated with Antimicrobial Resistance
2018 Standout
Acute phase response in animals: a review.
2009 Standout
Virulence factors of Bordetella bronchiseptica associated with the production of infectious atrophic rhinitis and pneumonia in experimentally infected neonatal swine
1987
Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis
1988
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Klebsiellaspp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors
1998 Standout
Global Epidemiology of Campylobacter Infection
2015 Standout
Oral immunization of mice with attenuated Salmonella typhimurium aroA expressing a recombinant Mycoplasma hyopneumoniae antigen (NrdF)
1997
Enteric Campylobacteria and RNA Viruses Associated with Healthy and Diarrheic Humans in the Chinook Health Region of Southwestern Alberta, Canada
2010
The bvgAS locus negatively controls motility and synthesis of flagella in Bordetella bronchiseptica
1992
Molecular Characterization of Acquired Enrofloxacin Resistance in Mycoplasma synoviae Field Isolates
2013
Phytoplasma: Phytopathogenic Mollicutes
2000 Standout
Molecular Biology and Pathogenicity of Mycoplasmas
1998 Standout
Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspecies
2005 Standout
Aggregative adherence of Klebsiella pneumoniae to human intestine-407 cells
1995
Molecular cloning and characterization of protective outer membrane protein P.69 from Bordetella pertussis.
1989
BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model
1994
Molecular characterization of a ribonucleotide reductase (nrdF) gene fragment of Mycoplasma hyopneumoniae and assessment of the recombinant product as an experimental vaccine for enzootic pneumonia
1996
Works of M. Kobisch being referenced
Use of recombinant ApxIV in serodiagnosis of Actinobacillus pleuropneumoniae infections, development and prevalidation of the ApxIV ELISA
2004
Analysis of putative ABC transporter genes in Mycoplasma hyopneumoniae
1996
Immunological and pathological reactions in piglets experimentally infected with Mycoplasma hyopneumoniae and/or Mycoplasma flocculare
1992
Evaluation of Bordetella bronchiseptica vaccines in specific-pathogen-free piglets with bacterial cell surface antigens in enzyme-linked immunosorbent assay
1985
Plasma Haptoglobin Concentration in Swine After Challenge withStreptococcus suis
2002
Cloning and expression of a species-specific early immunogenic 36-kilodalton protein of Mycoplasma hyopneumoniae in Escherichia coli
1991
Characterization of Mutations in DNA Gyrase and Topoisomerase IV Involved in Quinolone Resistance of Mycoplasma gallisepticum Mutants Obtained In Vitro
2002
A nested PCR assay for the detection of Mycoplasma hyopneumoniae in tracheobronchiolar washings from pigs
2000
Virulence of capsulated and noncapsulated isolates of Pasteurella multocida and their adherence to porcine respiratory tract cells and mucus
1993
Mycoplasma hyopneumoniae infection in pigs: duration of the disease and resistance to reinfection.
1993
Persistence of Mycoplasma hyopneumoniae in Experimentally Infected Pigs after Marbofloxacin Treatment and Detection of Mutations in the parC Gene
2006
Identification of a 68-kilodalton outer membrane protein as the major protective antigen of Bordetella bronchiseptica by using specific-pathogen-free piglets
1990